MetaADEDB 2.0 @ LMMD
sarpogrelate
(FFYNAVGJSYHHFO-UHFFFAOYSA-N)
Structure
SMILES
COc1cccc(c1)CCc1ccccc1OCC(OC(=O)CCC(=O)O)CN(C)C
Type(s)
Investigational
Molecular Formula:
C24H31NO6
Molecular Weight:
429.506
Log P:
3.1974
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
85.3
CAS Number(s):
125926-17-2; 2194540-32-2
Synonym(s)
1.
sarpogrelate
2.
2-(dimethylamino)-1-((2-(3-methoxyphenyl)phenoxy)methyl)ethyl hydrogensuccinate hydrochloride
3.
MCI 9042
4.
MCI-9042
5.
mono-(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl)succinate hydrochloride
External Link(s)
MeSHC064294
PubChem Compound5160
BindingDB50093789
ChEBI135697
CHEMBLCHEMBL52939
DrugBankDB12163
DrugCentral2423
IUPHAR/BPS Guide to PHARMACOLOGY210
KEGGdr:D08508
Therapeutic Target DatabaseD0G6VL
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AbasiaOFFSIDES
2Alanine Aminotransferase IncreasedOFFSIDES
3Albuminuria18235151CTD
4Altered state of consciousnessOFFSIDES
5AmphetaminesOFFSIDES
6ApathyOFFSIDES
7Arteriosclerosis Obliterans15080020CTD
OFFSIDES
8ArteriosclerosisOFFSIDES
9Atherosclerosis26950217CTD
10AuraOFFSIDES
11Bipolar DisorderOFFSIDES
12Blood aldosterone decreasedOFFSIDES
13Blood alkaline phosphatase increasedOFFSIDES
14Blood creatine phosphokinase increasedOFFSIDES
15Blood creatinine decreasedOFFSIDES
16Blood gases abnormalOFFSIDES
17Blood glucose decreasedOFFSIDES
18Blood lactate dehydrogenase increasedOFFSIDES
19Blood urea increasedOFFSIDES
20Body TemperatureOFFSIDES
21BradycardiaOFFSIDES
22BronchiolitisOFFSIDES
23Cardiomegaly11133011CTD
24Cardiovascular Diseases21183729CTD
25Cerebral Infarction18388340CTD
26CheilitisOFFSIDES
27Cold sweatOFFSIDES
28Completed SuicideOFFSIDES
29Coronary Restenosis17507105CTD
30Coronary Thrombosis17507105CTD
31CraniectomyOFFSIDES
32Cytomegalovirus test positiveOFFSIDES
33Depressed Level of ConsciousnessOFFSIDES
34Diabetes Mellitus, Experimental21183729CTD
35Diabetic Foot15080020CTD
36DyscalculiaOFFSIDES
37DysgeusiaOFFSIDES
38Electrocardiogram changeOFFSIDES
39Emotional disorderOFFSIDES
40Fatty Liver27133527CTD
41Fibrosis24107419CTD
42Gastric ulcerOFFSIDES
43Haptoglobin DecreasedOFFSIDES
44Heart failure18088389CTD
45HemiplegiaOFFSIDES
46HepatitisOFFSIDES
47HypoaldosteronismOFFSIDES
48Infusion site painOFFSIDES
49Infusion site swellingOFFSIDES
50Intestinal PerforationOFFSIDES
51Kidney Diseases27097221CTD
52Lymphocyte count decreasedOFFSIDES
53Mental impairmentOFFSIDES
54MoaningOFFSIDES
55Mucocutaneous rashOFFSIDES
56Nephritis, Interstitial24107419CTD
57Neutrophil count decreasedOFFSIDES
58Polyomavirus-associated nephropathyOFFSIDES
59Rebound effectOFFSIDES
60Red blood cell schistocytes presentOFFSIDES
61Renal tubular disorderOFFSIDES
62Renin decreasedOFFSIDES
63Retinal pigment epithelial tearOFFSIDES
64RhabdomyolysisOFFSIDES
65Right ventricular systolic pressure increasedOFFSIDES
66Scleroderma renal crisisOFFSIDES
67Sleep TalkingOFFSIDES
68Stenotrophomonas infectionOFFSIDES
69StridorOFFSIDES
70Thrombosis22785018CTD
71Urine potassium decreasedOFFSIDES
72Wound InfectionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.